002680SZSE

Announcement on the Progress of the Company's Investigation by the China Securities Regulatory Commission and Risk Warning

Changsheng Retreat Co., Ltd.·September 9, 2019·2 pages

✨ AI Summary

This announcement informs stakeholders about the ongoing investigation by the China Securities Regulatory Commission (CSRC) due to the company's failure to disclose its 2018 annual report on time. The company has not yet received conclusive findings from the CSRC. During the investigation, the company will cooperate fully and provide monthly updates on the situation and potential risks of stock suspension.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

长生生物科技股份有限公司证券代码：002680 证券简称：*ST长生
公告编号：2019-043

Announcement on the Progress of the Company's Investigation by the China Securities Regulatory Commission and Risk Warning

The company and all members of the board guarantee that the information disclosed is true, accurate, and complete, without false records, misleading statements, or significant omissions.

长生生物科技股份有限公司 (hereinafter referred to as "the Company") received the "Investigation Notice" (Su Zheng Diao Zi 2019035) from the China Securities Regulatory Commission (hereinafter referred to as "CSRC") on May 10, 2019, due to the failure to disclose the 2018 annual report within the statutory deadline, leading to the initiation of an investigation.

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.